Livzon pharmaceutical group actively repurchases A-shares

Livzon Pharmaceutical Group has been actively repurchasing its A-shares, with the most recent activity on September 18, 2025. On this date, the company repurchased 125,700 A-shares through the Shenzhen Stock Exchange at prices ranging from yuan 39.32 to yuan 40.35, totaling yuan 4,996,810. These shares are currently held as treasury stock. The total number of repurchased shares yet to be canceled stands at 125,700.

This follows a series of repurchases dating back to December 2024, with numerous transactions occurring in January, February, April, July, August, and September 2025. For instance, on December 25, 2024, 145,700 A-shares were bought back at yuan 37.75, representing 0.0157% of the existing shares. Similarly, on August 14, 2025, 125,200 A-shares were repurchased at yuan 39.91. These repurchases demonstrate a consistent effort by Livzon Pharmaceutical Group to manage its share capital.

The company's board officially authorized these repurchases on April 24, 2025, confirming adherence to regulatory requirements. As of September 18, 2025, the total issued A-shares remain at 604,293,313, with 0 treasury shares. The company’s total H-shares remain at 299,807,117 with 0 treasury shares.